Use of pump-assisted hemofiltration in children with acute renal failure

Area of Science:

• Pediatric Nephrology
• Critical Care Medicine
• Renal Replacement Therapy

Background:

• Acute renal failure (ARF) in critically ill children carries a high mortality rate.
• Effective renal replacement therapies are crucial for managing pediatric ARF.
• Pump-assisted hemofiltration (PAHF) offers a potential solution for fluid and solute management.

Purpose of the Study:

• To evaluate the outcomes and complications of pump-assisted hemofiltration (PAHF) in critically ill children with ARF.
• To assess the efficacy of using a standard volumetric pump for blood flow regulation during PAHF.
• To determine the safety and practicality of PAHF in a pediatric critical care setting.

Main Methods:

• Retrospective review of 52 critically ill children with ARF treated with PAHF between 1989 and 1995.
• Analysis of patient demographics, underlying diagnoses, duration of PAHF, and fluid management.
• Documentation of laboratory control, need for additional dialysis, and specific complications.

Main Results:

• PAHF was utilized for an average of 9 days in children with diverse underlying conditions, primarily congenital heart disease and infection.
• Efficient management of laboratory abnormalities was achieved, with only 4 patients requiring additional hemodialysis.
• Common complications included electrolyte imbalances (hyponatremia, hypokalemia), hypovolemia, hyperglycemia, and bleeding, with no pump-specific issues.

Conclusions:

• Pump-assisted hemofiltration (PAHF) using a volumetric infusion pump is a practical and efficient therapeutic option for critically ill children with ARF.
• PAHF demonstrates effective solute and fluid management in this vulnerable pediatric population.
• The therapy is associated with manageable complications, highlighting its utility in pediatric critical care.